This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mitchell, C. Articles by Gilgenkrantz, H. Search for Related Content PubMed PubMed Citation Articles by Mitchell, C. Articles by Gilgenkrantz, H.

(American Journal of Pathology. 2002;160:31-35.)
© 2002 American Society for Investigative Pathology

Short Communications

Liver Repopulation by Bcl-x_L Transgenic Hepatocytes

From the Department of Genetics, Development and Molecular Pathology, Institut Cochin de Génétique Moléculaire, Paris, France

Liver repopulation could constitute a potential therapeutic alternative to liver transplantation in the future. Therefore, the development of liver repopulation strategies is of major interest. We have previously reported that Bcl-2-expressing hepatocytes are resistant to Fas-mediated apoptosis and that these hepatocytes, when transplanted into the spleen, are able to repopulate the liver of normal mice submitted to Fas-mediated apoptosis. We now show that Bcl-x_L-overexpressing hepatocytes are able to repopulate up to 10% of a normal mouse liver treated with successive injections of anti-Fas antibody. We show that a twofold overexpression of Bcl-x_L is sufficient to confer a selective advantage to hepatocytes submitted to anti-Fas antibody. Moreover, repopulation percentages obtained here were comparable to those obtained when Bcl-2 hepatocytes were transplanted, suggesting that both proteins are equivalent in conferring a selective advantage to hepatocytes submitted to anti-Fas antibody.